NEUARTIGE VERBINDUNGEN

European patent · EP2922549 · Deleted

Register entry

Publication number
EP2922549
Application number
EP13857477
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Nov 18, 2013
Published
Sep 30, 2015
Granted
Jun 21, 2017
Deleted
Nov 30, 2019
Reason
Annual fee unpaid
IPC classes
A61K 31/519 (2006.01)
C07D 487/04 (2006.01)
Priority
US 201261728390 P 20.11.2012
US 201361774087 P 07.03.2013
PCT application
PCT/US2013/070472 18.11.2013
PCT publication
WO2014/081645 30.05.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 17, 2020

    Deleted, fee unpaid

    Published in Swissreg on 17.06.2020

  2. Aug 10, 2017

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 10.08.2017

  3. Jun 21, 2017

    Granted

    Published in Swissreg on 21.06.2017

Parties

Holder

GlaxoSmithKline LLC

Corporation Service Company 251 Little Falls Drive, Wilmington, Delaware 19808, US

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

COE, Diane Mary

Stevenage Hertfordshire SG1 2NY, GB

SMITH, Stephen Allan

Stevenage Hertfordshire SG1 2NY, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.